Supramolecular hydrogel for programmable delivery of therapeutics to cancer multidrug resistance

Multidrug resistance (MDR) has been considered as a major adversary in oncologic chemotherapy. To simultaneously overcome drug resistance and inhibit tumor growth, it is essential to develop a drug delivery system that can carry and release multiple therapeutic agents with spatiotemporal control. In...

Full description

Saved in:
Bibliographic Details
Published in:Biomaterials advances 2023-03, Vol.146, p.213282-213282, Article 213282
Main Authors: Chen, Liang-Hsin, Liang, Nai-Wen, Huang, Wei-Yuan, Liu, Yu-Chung, Ho, Chia-Yu, Kuan, Chen-Hsiang, Huang, Yu-Fen, Wang, Tzu-Wei
Format: Article
Language:English
Subjects:
Cell Line, Tumor
Doxorubicin - pharmacology
Doxorubicin - therapeutic use
Drug Delivery Systems
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Humans
Hydrogels - pharmacology
Neoplasms - drug therapy
RNA, Small Interfering
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multidrug resistance (MDR) has been considered as a major adversary in oncologic chemotherapy. To simultaneously overcome drug resistance and inhibit tumor growth, it is essential to develop a drug delivery system that can carry and release multiple therapeutic agents with spatiotemporal control. In this study, we developed a hydrogel containing an enzyme-cleavable peptide motif, with a network structure formed by 4-armed polyethylene glycol (PEG) crosslinked by complementary nucleic acid sequences. Hydrogen bond formation between nucleobase pairing allows the hydrogel to be injectable, and the peptide motif grants deliberate control over hydrogel degradation and the responsive drug release. Moreover, MDR-targeted siRNAs are complexed with stearyl-octaarginine (STR-R8), while doxorubicin (Dox) is intercalated with DNA and nanoclay structures in this hydrogel to enhance therapeutic efficacy and overcome MDR. The results show a successful configuration of a hydrogel network with in situ gelation property, injectability, and degradability in the presence of tumor-associated enzyme, MMP-2. The synergistic effect by combining MDR-targeted siRNAs and Dox manifests with the enhanced anti-cancer effect on drug resistant breast cancer cells in both in vitro and in vivo tumor models. We suggest that with the tailor-designed hydrogel system, multidrug resistance in tumor cells can be significantly inhibited by the co-delivery of multiple therapeutics with spatial-temporal control release.
ISSN:2772-9508
2772-9508
DOI:10.1016/j.bioadv.2023.213282